Valuation : 10x Genomics, Inc.

Market Cap 8.77B 7.54B 7.1B 6.47B 12.11B 834B 12.16B 84.19B 32.54B 425B 32.92B 32.21B 1,346B P/E 2026 *
-93.7x
P/E 2027 * -97.1x
Enterprise Value 8.3B 7.14B 6.73B 6.13B 11.47B 790B 11.51B 79.73B 30.81B 402B 31.18B 30.5B 1,275B EV / Sales 2026 *
13.4x
EV / Sales 2027 * 12.1x
Free-Float
90.86%
Yield 2026 *
-
Yield 2027 * -
1 day+2.58%
1 week+9.15%
Current month+7.75%
1 month+29.33%
3 months+119.97%
6 months+221.81%
Current year+312.57%
1 week 60.99
Extreme 60.99
67.62
1 month 55.25
Extreme 55.25
67.62
Current year 15.9
Extreme 15.9
67.62
1 year 11.16
Extreme 11.16
67.62
3 years 6.78
Extreme 6.78
67.62
5 years 6.78
Extreme 6.78
187.85
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 02/07/2012
President 51 01/10/2012
Director of Finance/CFO 51 12/08/2024
Director TitleAgeSince
Director/Board Member 51 02/07/2012
Director/Board Member 49 02/07/2012
Chairman 68 01/08/2013
Date Insider Type Main position Quantity % Market Cap. Importance
03/09/26 Sell

Chairman

-20,000 0.0166%
01/09/26 Don

Founder

-100 0.0001%
26/08/26 Sell

Founder

-10,486 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
+2.58%+9.15%+398.44%+42.08% 8.77B
+1.12%-0.17%+173.86%+382.74% 21.84B
+1.53%-4.15%-37.02%-20.94% 9.81B
-3.18%-3.10%-29.22% - 6.79B
+0.26%-0.11%+82.86%+51.66% 6.57B
-1.42%-2.98%-29.46%-20.49% 5.75B
+0.78%-2.84%-8.56%-19.67% 4.26B
-2.77%-4.25%+63.66%+79.79% 4.08B
-0.53%-2.70%-23.88%-30.15% 2.73B
+19.99%+32.96% - - 1.49B
Average +1.84%+0.37%+65.63%+58.13% 7.21B
Weighted average by Cap. +0.75%-0.30%+102.87%+139.56%

Financials

2026 *2027 *
Net sales 620M 534M 502M 458M 856M 59B 860M 5.95B 2.3B 30.06B 2.33B 2.28B 95.22B 680M 585M 551M 502M 939M 64.71B 943M 6.53B 2.52B 32.97B 2.55B 2.5B 104B
Net income -94.29M -81.14M -76.4M -69.61M -130M -8.97B -131M -905M -350M -4.57B -354M -346M -14.48B -88.67M -76.3M -71.84M -65.46M -122M -8.44B -123M -851M -329M -4.3B -333M -326M -13.62B
Net Debt -465M -400M -377M -343M -642M -44.25B -645M -4.47B -1.73B -22.54B -1.75B -1.71B -71.41B -521M -448M -422M -385M -720M -49.57B -722M -5B -1.93B -25.25B -1.96B -1.91B -80B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
09/09/26 $67.29 +2.58% 2,767,343
08/09/26 $65.60 +4.71% 3,382,284
04/09/26 $62.65 -0.90% 1,469,824
03/09/26 $63.22 +2.55% 2,172,711
02/09/26 $61.65 +2.78% 1,604,988
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
67.29USD
Average target price
52.13USD
Spread / Average Target
-22.52%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!